4T1是一種乳癌細胞系,來源於BALB/c小鼠的癌變乳腺組織,4T1細胞帶有上皮細胞的性質,並且能耐受腫瘤藥物6-硫鳥嘌呤[1]。4T1細胞是一種雌激素受體(ER)、孕酮受體(PR)和人表皮生長因子受體-2(Her⁃2)均為陰性的乳腺癌細胞[2]。在科研中,4T1細胞常用作乳腺癌遠端轉移的研究模型[3]及臨床藥物篩選使用最多的乳腺癌模型[4][5],這些細胞對小鼠組織有著很高的侵襲性[6]

參考文獻

  1. ^ Pulaski, BA; Ostrand-Rosenberg, S. Mouse 4T1 breast tumor model. Current Protocols in Immunology. May 2001, 20 (20). PMID 18432775. doi:10.1002/0471142735.im2002s39. 
  2. ^ 黃迪; 黃宇; 翁傑鋒; 黃子聖; 麥振豪; 趙俐; 古維立. Reversine對小鼠乳腺癌4T1細胞增殖和凋亡的調控及相關作用機制的研究. 實用醫學雜志. 2018, 34 (14): 2324-2328 [2019-11-19]. doi:10.3969/j.issn.1006-5725.2018.14.011. [失效連結]
  3. ^ Shengyu, Yang; et al. Mouse Models for Tumor Metastasis. Methods in Molecular Biology. 2012, 928: 221–228. PMC 3674868 . doi:10.1007/978-1-62703-008-3_17. 
  4. ^ Tao, K; Fang, M; Alroy, J; Sahagian, GG. Imagable 4T1 model for the study of late stage breast cancer.. BMC cancer. 2008-08-09, 8: 228 [2019-11-19]. PMID 18691423. doi:10.1186/1471-2407-8-228. 
  5. ^ Liao, D; Luo, Y; Markowitz, D; Xiang, R; Reisfeld, RA. Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model.. PloS one. 2009-11-23, 4 (11): e7965 [2019-11-19]. PMID 19956757. doi:10.1371/journal.pone.0007965. 
  6. ^ Disch, Bryan; et al. Development and Characterization of a Preclinical Model of Breast Cancer Lung Micrometastatic to Macrometastatic Progression. PLoS ONE. 30 May 2014, 9 (5) [2020-12-07]. PMC 4039511 . doi:10.1371/journal.pone.0098624. (原始內容存檔於2020-09-18). 

外部鏈接